• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎治疗共识 - 巴西皮肤病学会

Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.

作者信息

Magalhães Renata Ferreira, Rivitti-Machado Maria Cecília, Duarte Gleison Vieira, Souto Roberto, Nunes Daniel Holthausen, Chaves Mario, Hirata Sérgio Henrique, Ramos Andrea Machado Coelho

机构信息

Department of Internal Medicine, Universidade Estadual de Campinas, Campinas, SP, Brazil.

Dermatology Outpatient Clinic, Hospital de Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

An Bras Dermatol. 2019 Apr;94(2 Suppl 1):7-19. doi: 10.1590/abd1806-4841.20198607. Epub 2019 Jun 3.

DOI:10.1590/abd1806-4841.20198607
PMID:31166401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6544037/
Abstract

Hidradenitis suppurativa is a chronic immune mediated disease of universal distribution that causes great damage to the quality of life of the affected individual, whose prevalence is estimated at 0.41% in the Brazilian population. The objective of this work was update on physiopathogenesis, diagnosis and classification of hidradenitis suppurativa and to establish therapeutic recommendations in the Brazilian reality. It was organized as a work group composed of eight dermatologists from several institutions of the country with experience in the treatment of hidradenitis suppurativa and carried out review on the topic. Recommendations were elaborated and voted by modified Delphi system and statistical analysis of the results was performed. The Brazilian consensus on the clinical approach of hidradenitis suppurativa had the support of the Brazilian Society of Dermatology.

摘要

化脓性汗腺炎是一种普遍分布的慢性免疫介导性疾病,对受影响个体的生活质量造成极大损害,据估计其在巴西人群中的患病率为0.41%。这项工作的目的是更新化脓性汗腺炎的生理病理学、诊断和分类,并在巴西的实际情况下制定治疗建议。它被组织成一个工作组,由来自该国多个机构的八位皮肤科医生组成,他们在化脓性汗腺炎的治疗方面具有经验,并对该主题进行了综述。通过改良的德尔菲系统制定并投票表决了建议,并对结果进行了统计分析。关于化脓性汗腺炎临床治疗方法的巴西共识得到了巴西皮肤病学会的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aee/6544037/d9af933458fc/abd-94-02-s1-0007-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aee/6544037/d9af933458fc/abd-94-02-s1-0007-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aee/6544037/d9af933458fc/abd-94-02-s1-0007-g01.jpg

相似文献

1
Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.化脓性汗腺炎治疗共识 - 巴西皮肤病学会
An Bras Dermatol. 2019 Apr;94(2 Suppl 1):7-19. doi: 10.1590/abd1806-4841.20198607. Epub 2019 Jun 3.
2
Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence.自动国际化脓性汗腺炎严重程度评分系统 (AIHS4):一种使用人工智能评估化脓性汗腺炎严重程度的新工具。
Skin Res Technol. 2023 Jun;29(6):e13357. doi: 10.1111/srt.13357.
3
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
4
Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia.沙特阿拉伯关于化脓性汗腺炎未满足需求、转诊标准和治疗目标的专家共识。
J Dermatolog Treat. 2024 Dec;35(1):2353693. doi: 10.1080/09546634.2024.2353693. Epub 2024 Jun 11.
5
Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.化脓性汗腺炎:法国皮肤科诊疗指南的影响
Ann Dermatol Venereol. 2023 Sep;150(3):227-229. doi: 10.1016/j.annder.2022.09.008. Epub 2023 Mar 7.
6
[CME Dermatology 23/Answers: Hidradenitis suppurativa].[继续医学教育皮肤科23/答案:化脓性汗腺炎]
Praxis (Bern 1994). 2021 Jun;110(8):471-472. doi: 10.1024/1661-8157/a003694.
7
The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.患有化脓性汗腺炎患者的代谢综合征患病率。
J Am Acad Dermatol. 2014 Apr;70(4):699-703. doi: 10.1016/j.jaad.2013.11.014. Epub 2014 Jan 13.
8
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.《化脓性汗腺炎患者的住院管理:德尔菲共识研究》
Cutis. 2024 Jun;113(6):251-254. doi: 10.12788/cutis.1027.
9
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.评估妊娠和产后期间的化脓性汗腺炎疾病进程。
JAMA Dermatol. 2020 Jun 1;156(6):681-685. doi: 10.1001/jamadermatol.2020.0777.
10
Low Utilization of the Dermatology Ambulatory Encounter among Patients with Hidradenitis Suppurativa: A Population-Based Retrospective Cohort Analysis in the USA.美国基于人群的回顾性队列分析:患有化脓性汗腺炎的患者皮肤科门诊就诊率低。
Dermatology. 2017;233(5):396-398. doi: 10.1159/000480379. Epub 2017 Sep 28.

引用本文的文献

1
Preoperative Tunnel Measurement in Hidradenitis Suppurativa: Comparison of Palpation and Ultrasound.化脓性汗腺炎术前隧道测量:触诊与超声检查的比较
Diagnostics (Basel). 2025 Jun 5;15(11):1442. doi: 10.3390/diagnostics15111442.
2
Management of hidradenitis suppurativa in Tunisia: A Delphi expert consensus.突尼斯化脓性汗腺炎的管理:德尔菲专家共识
J Cutan Aesthet Surg. 2025 Apr-Jun;18(2):92-100. doi: 10.25259/jcas_166_23. Epub 2024 Sep 20.
3
Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis.

本文引用的文献

1
Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.将皮肤和血液转录组与血清蛋白质组整合在化脓性汗腺炎中,揭示了补体失调和浆细胞特征。
PLoS One. 2018 Sep 28;13(9):e0203672. doi: 10.1371/journal.pone.0203672. eCollection 2018.
2
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.化脓性汗腺炎/反向痤疮:治疗优化的实用框架 - HS ALLIANCE 工作组的系统评价和建议。
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):19-31. doi: 10.1111/jdv.15233. Epub 2018 Oct 23.
3
螺内酯治疗育龄期女性化脓性汗腺炎的疗效:一项单中心回顾性分析
Int J Womens Dermatol. 2024 Jul 1;10(3):e159. doi: 10.1097/JW9.0000000000000159. eCollection 2024 Oct.
4
Doppler ultrasound protocol for patients with hidradenitis suppurativa.化脓性汗腺炎患者的多普勒超声检查方案。
An Bras Dermatol. 2024 Sep-Oct;99(5):670-679. doi: 10.1016/j.abd.2023.10.003. Epub 2024 Jun 8.
5
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?靶向治疗免疫介导性皮肤病。皮肤科医生应该知道什么?
An Bras Dermatol. 2024 Jul-Aug;99(4):546-567. doi: 10.1016/j.abd.2023.10.002. Epub 2024 Mar 22.
6
Access to dermatologic care and provider impact on hidradenitis suppurativa care: global survey insights.获得皮肤科护理及医疗服务提供者对化脓性汗腺炎护理的影响:全球调查见解
Int J Womens Dermatol. 2024 Jan 18;10(1):e130. doi: 10.1097/JW9.0000000000000130. eCollection 2024 Mar.
7
Is Exploration of Alternate Immune Pathways Needed in Hidradenitis Suppurativa? A Case of Atopic Dermatitis and Concurrent Hidradenitis Suppurativa Responding to Dupilumab.化脓性汗腺炎是否需要探索其他免疫途径?1例特应性皮炎合并化脓性汗腺炎患者对度普利尤单抗治疗有效。
Case Rep Dermatol Med. 2023 Oct 23;2023:5189034. doi: 10.1155/2023/5189034. eCollection 2023.
8
Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms.探究化脓性汗腺炎患者生活的多维影响:一项关于社交媒体平台的深度网络民族志研究
Dermatol Ther (Heidelb). 2023 Nov;13(11):2797-2815. doi: 10.1007/s13555-023-01032-9. Epub 2023 Oct 4.
9
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options.儿童和青少年化脓性汗腺炎:药物治疗选择的最新进展。
Paediatr Drugs. 2023 Nov;25(6):659-676. doi: 10.1007/s40272-023-00595-6. Epub 2023 Oct 2.
10
Hidradenitis suppurativa - biologic therapy and other available treatment options.化脓性汗腺炎——生物治疗及其他可用的治疗选择。
Postepy Dermatol Alergol. 2023 Aug;40(4):518-528. doi: 10.5114/ada.2021.112075. Epub 2022 Jan 18.
T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities.
在化脓性汗腺炎/反向痤疮中,辅助性 T 细胞 17/调节性 T 细胞失衡:与毛囊切开术、肥胖、吸烟和自身免疫性合并症的关联。
Br J Dermatol. 2018 Aug;179(2):260-272. doi: 10.1111/bjd.16561. Epub 2018 Jun 11.
4
Axillary Hidradenitis: Risk Factors for Recurrence after Surgical Excision in 214 Patients.腋窝汗腺炎:214例患者手术切除后复发的危险因素
Am Surg. 2018 Mar 1;84(3):422-427.
5
Prevalence of hidradenitis suppurativa in Brazil: a population survey.巴西化脓性汗腺炎的患病率:一项人口调查。
Int J Dermatol. 2018 May;57(5):618-620. doi: 10.1111/ijd.13937. Epub 2018 Mar 8.
6
Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients.化脓性汗腺炎的外科治疗:255 例患者的术后结局、美容效果和生活质量分析。
J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1570-1574. doi: 10.1111/jdv.14892. Epub 2018 Mar 23.
7
Dermatological indications for the use of isotretinoin beyond acne.异维A酸在痤疮以外的皮肤科适应症。
J Dermatolog Treat. 2018 Nov;29(7):698-705. doi: 10.1080/09546634.2018.1445194. Epub 2018 Mar 14.
8
Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures.广泛切除和二期愈合治疗化脓性汗腺炎:253 例手术后有意义的局部治愈率。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):459-462. doi: 10.1111/jdv.14770. Epub 2018 Jan 17.
9
Consensus on the management of patients with psoriatic arthritis in a dermatology setting.皮肤科中银屑病关节炎患者管理的共识。
J Eur Acad Dermatol Venereol. 2018 Apr;32(4):515-528. doi: 10.1111/jdv.14741. Epub 2018 Jan 11.
10
Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies.接受阿达木单抗治疗的化脓性汗腺炎患者的无感染临床反应:两项3期研究的结果
Wounds. 2017 Nov;29(11):E98-E102.